OBiO Technology (Shanghai) Corp., Ltd. (hereinafter referred to as the "company" or "OBiO") is a domestic leading high-tech enterprise, which focuses on viral vector packaging service for both basic life science research and gene & cell therapy drug development and clinical preparation in China. Since established in March 2013, OBiO has got over 100 million RMB of equity financing, and was listed on “National equities exchange and quotations” (NEEQ Market, ID:839702, stock name: Heyuan Shanghai), Dec. 16th, 2016. The average growth rate of annual sales revenue is more than 50% over the past five years. With all the staff’s efforts, OBiO had got a lot of honors. Now, OBiO is a “Good Faith Enterprise of Shanghai”, “technical innovation and quality service organization of small and medium-sized enterprises of Shanghai” and “expertise-focus-special-new enterprise of Shanghai”.